Compare VRCA & CHPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VRCA | CHPG |
|---|---|---|
| Founded | 2013 | 2024 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 112.4M | 102.6M |
| IPO Year | 2018 | N/A |
| Metric | VRCA | CHPG |
|---|---|---|
| Price | $6.95 | $10.31 |
| Analyst Decision | Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $17.00 | N/A |
| AVG Volume (30 Days) | ★ 153.8K | 20.1K |
| Earning Date | 03-10-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.04 |
| Revenue | ★ $30,829,000.00 | N/A |
| Revenue This Year | $372.93 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $265.87 |
| Revenue Growth | ★ 234.73 | N/A |
| 52 Week Low | $3.28 | $9.81 |
| 52 Week High | $9.82 | $10.32 |
| Indicator | VRCA | CHPG |
|---|---|---|
| Relative Strength Index (RSI) | 42.13 | N/A |
| Support Level | $6.52 | N/A |
| Resistance Level | $7.84 | N/A |
| Average True Range (ATR) | 0.43 | 0.00 |
| MACD | -0.10 | 0.00 |
| Stochastic Oscillator | 23.25 | 0.00 |
Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a contagious and pediatric viral skin disease, and common warts.
Championsgate Acquisition Corp is a blank check company.